Is Carbamazepine Capsule, Extended Release (Carbatrol) in shortage?
Carbamazepine Capsule, Extended Release is listed by FDA as being discontinued by at least one maker (updated Dec 19, 2025).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)
Discontinuation of the manufacture of the drug
Maker contact: 855-268-1825
- Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)
Discontinuation of the manufacture of the drug
Maker contact: 855-268-1825
- Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)
Discontinuation of the manufacture of the drug
Maker contact: 855-268-1825
FDA recalls of Carbamazepine
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Carbamazepine Capsule, Extended Release:
- Amerisource Health Services LLC recalls Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American
- Torrent Pharma Inc. recalls Carbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactured by: Torrent Pharmaceuticals Ltd.
- The Harvard Drug Group recalls Carbamazepine 200mg Tablets, USP, 200 mg, 100 Count Unit Dose Cartons, Rx only, Manufactured by: Torrent
- Torrent Pharma Inc. recalls Carbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent Pharmaceuticals
- Taro Pharmaceuticals U.S.A., Inc. recalls Carbamazepine Tablets USP, 200 mg, 1000 Tablets per Bottle, Rx only, Manufactured by: Taro Pharmaceutical Industries
Carbamazepine Capsule, Extended Release shortage questions
Is Carbamazepine Capsule, Extended Release (Carbatrol) in shortage?
Carbamazepine Capsule, Extended Release is listed by FDA as being discontinued by at least one maker (updated Dec 19, 2025).
What should I do if I can’t get Carbamazepine Capsule, Extended Release?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.